EFI Lake Geneva Ventures is a seed and early-stage investment fund based in Geneva, Switzerland. Founded in 2020, our mission is to foster innovation by investing at early-stage in fast-growing IP-driven companies accross sectors, mainly in Switzerland.
Location: Switzerland, Geneva
Employees: 1-10
Founded date: 2020
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A
Portfolio 23
| Date | Name | Website | Total Raised | Location |
| 10.01.2024 | Hemotune | hemotune.ch | $28.74M | - |
| 27.10.2023 | nsave | nsave.com | $4M | United Kin... |
| 10.07.2023 | Impossible... | impossiblematerials.com | $6.05M | United Kin... |
| 05.04.2023 | Impossible... | impossible-materials.jimdosite.com | $3.8M | - |
| - | Aptissen S... | aptissen.com | - | Switzerlan... |
| - | Kejako | kejako.com | - | - |
| - | Faitron | faitron.com | - | Switzerlan... |
| - | CELLnTEC A... | cellntec.com | - | Switzerlan... |
| - | EBAMed | eba-med.com | $16.94M | Switzerlan... |
| - | Abionic SA | abionic.com | $24.94M | Switzerlan... |
Show more
Mentions in press and media 6
| Date | Title | Description |
| 25.03.2024 | CHF 14 million to fund hemotune’s clinical trials | The HemoSystem, a breakthrough blood purification platform based on nanoengineered magnetic beads, stands out for its ability to effectively remove large biomolecules directly from patients' bloodstreams, offering a unique approach to impl... |
| 05.09.2023 | Hylomorph secures CHF 4.5m ahead of market launch | |
| 28.06.2023 | EUR 14.35 million to advance cardiac radiation ablation therapy | |
| 05.04.2023 | CHF 3.4 million to accelerate Impossible Materials market entry | |
| 01.03.2023 | FluoSphera secures $1 million pre-seed investment | |
| 17.02.2023 | CHF 2.3M to market Terapet first product and boost R&D |